Peripheral blood DNA methylation signatures predict response to vedolizumab and ustekinumab in adult patients with Crohn’s disease: The EPIC-CD study
View ORCID ProfileVincent W. Joustra, View ORCID ProfileAndrew Y.F. Li Yim, View ORCID ProfilePeter Henneman, View ORCID ProfileIshtu Hageman, Tristan de Waard, View ORCID ProfileEvgeni Levin, View ORCID ProfileAlexandra J. Noble, View ORCID ProfileThomas P. Chapman, View ORCID ProfileFemke Mol, Sarah van Zon, Donghyeok Lee, View ORCID ProfileColleen G.C. McGregor, View ORCID ProfileAlex T. Adams, View ORCID ProfileJack J. Satsangi, View ORCID ProfileWouter J. de Jonge, View ORCID ProfileGeert R. D’Haens, EPIC-CD Consortium
doi: https://doi.org/10.1101/2024.07.25.24310949
Vincent W. Joustra
1Amsterdam UMC - University of Amsterdam, Department of Gastroenterology & Hepatology, Amsterdam, The Netherlands
Andrew Y.F. Li Yim
2Amsterdam UMC - University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam, The Netherlands
3Amsterdam UMC - University of Amsterdam, Genome Diagnostics Laboratory, Department of Human Genetics, Amsterdam, The Netherlands
Peter Henneman
3Amsterdam UMC - University of Amsterdam, Genome Diagnostics Laboratory, Department of Human Genetics, Amsterdam, The Netherlands
Ishtu Hageman
1Amsterdam UMC - University of Amsterdam, Department of Gastroenterology & Hepatology, Amsterdam, The Netherlands
2Amsterdam UMC - University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam, The Netherlands
Tristan de Waard
4Horaizon BV, Delft, The Netherlands
Evgeni Levin
4Horaizon BV, Delft, The Netherlands
Alexandra J. Noble
5Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Translational Gastroenterology Unit & NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
Thomas P. Chapman
5Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Translational Gastroenterology Unit & NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
6Department of Gastroenterology, St Richard’s and Worthing Hospitals, University Hospitals Sussex NHS Foundation Trust, West Sussex, UK
Femke Mol
2Amsterdam UMC - University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam, The Netherlands
Sarah van Zon
1Amsterdam UMC - University of Amsterdam, Department of Gastroenterology & Hepatology, Amsterdam, The Netherlands
Donghyeok Lee
4Horaizon BV, Delft, The Netherlands
Colleen G.C. McGregor
5Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Translational Gastroenterology Unit & NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
Alex T. Adams
5Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Translational Gastroenterology Unit & NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
Jack J. Satsangi
5Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Translational Gastroenterology Unit & NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
Wouter J. de Jonge
2Amsterdam UMC - University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam, The Netherlands
7University of Bonn, Department of Surgery, Germany
Geert R. D’Haens
1Amsterdam UMC - University of Amsterdam, Department of Gastroenterology & Hepatology, Amsterdam, The Netherlands
Article usage
Posted July 25, 2024.
Peripheral blood DNA methylation signatures predict response to vedolizumab and ustekinumab in adult patients with Crohn’s disease: The EPIC-CD study
Vincent W. Joustra, Andrew Y.F. Li Yim, Peter Henneman, Ishtu Hageman, Tristan de Waard, Evgeni Levin, Alexandra J. Noble, Thomas P. Chapman, Femke Mol, Sarah van Zon, Donghyeok Lee, Colleen G.C. McGregor, Alex T. Adams, Jack J. Satsangi, Wouter J. de Jonge, Geert R. D’Haens, EPIC-CD Consortium
medRxiv 2024.07.25.24310949; doi: https://doi.org/10.1101/2024.07.25.24310949
Peripheral blood DNA methylation signatures predict response to vedolizumab and ustekinumab in adult patients with Crohn’s disease: The EPIC-CD study
Vincent W. Joustra, Andrew Y.F. Li Yim, Peter Henneman, Ishtu Hageman, Tristan de Waard, Evgeni Levin, Alexandra J. Noble, Thomas P. Chapman, Femke Mol, Sarah van Zon, Donghyeok Lee, Colleen G.C. McGregor, Alex T. Adams, Jack J. Satsangi, Wouter J. de Jonge, Geert R. D’Haens, EPIC-CD Consortium
medRxiv 2024.07.25.24310949; doi: https://doi.org/10.1101/2024.07.25.24310949
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2837)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12543)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4418)
- Geriatric Medicine (401)
- Health Economics (712)
- Health Informatics (2844)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4172)
- Nursing (220)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6763)
- Radiology and Imaging (1486)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (472)
- Toxicology (57)
- Transplantation (200)
- Urology (173)